ChIP-chip data for identifying target genes and consensus binding sequences of mutant p53 in MDA-MB-468 breast cancer

Mai Nhu Uyen Le1, Yichong Ning1,2, Jianlin Zhou1

  • 1State Key Laboratory of Developmental Biology of Freshwater Fish & Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education, College of Life Science, Hunan Normal University, Changsha, Hunan 410081, China.

Data in Brief
|September 4, 2023
PubMed

Insights

Mutant p53, common in triple-negative breast cancer (TNBC), alters gene targets. This study used ChIP-chip to identify genes regulated by the p53 R273H mutation, aiding understanding of its oncogenic role.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Genomics

Background:

  • The TP53 gene, encoding the tumor suppressor p53 protein, is frequently mutated in human cancers, especially triple-negative breast cancer (TNBC).
  • TP53 mutations, often missense mutations in exons 5-8, affect the DNA-binding domain, altering p53's target gene specificity.
  • Understanding the target genes of mutant p53 is crucial for elucidating its oncogenic mechanisms.

Purpose of the Study:

  • To identify target genes regulated by the common p53 R273H mutant.
  • To characterize the DNA-binding motifs of the p53 R273H mutant.
  • To provide data for further investigation into the molecular mechanisms of mutant p53's oncogenic activity.

Main Methods:

  • Chromatin immunoprecipitation followed by DNA microarray (ChIP-chip) was employed.
  • The TNBC cell line MDA-MB-468 with endogenous p53-R273H mutation was used.
  • p53-bound DNA was identified using a p53 monoclonal antibody and cohybridized with a promoter array.

Main Results:

  • ChIP-chip analysis identified specific DNA regions bound by the p53 R273H mutant.
  • The study generated data on target genes and consensus binding motifs for the p53 R273H mutant.
  • Raw and analyzed data are available for further research.

Conclusions:

  • The identified target genes and binding motifs provide insights into the function of mutant p53.
  • This research contributes to understanding the molecular basis of p53-driven oncogenesis in TNBC.
  • The data facilitates further studies on the oncogenic activity of mutant p53.